Asian quake highlights medtech input needs
This article was originally published in Clinica
The need for a co-ordinated international approach and better readiness to provide large-scale emergency medical and other aid came to the fore again last week in the wake of the southern Asia earthquake. As Clinica went to press, the World Health Organization launched a $22m appeal for medical aid, notably surgical supplies and equipment, after reporting the total destruction of healthcare facilities, mainly in Pakistani Kashmir.
You may also be interested in...
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.